← Open Payments lookup

MARC CANTILLON: Open Payments

NPI 1427037803 · LIVINGSTON, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$33,879 in 128 payments from 14 companies in 2025. Trend: 2023 $20,365 · 2024 $22,646 · 2025 $33,879

Speaker / faculty: $29,745Food & beverage: $3,024Travel & lodging: $1,091Education: $19
CompanyPaymentsAmount
E.R. Squibb & Sons, L.L.C.36$24,349
ABBVIE INC.39$8,193
Axsome Therapeutics, Inc.7$326
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)11$271
Vanda Pharmaceuticals Inc.13$164
Teva Pharmaceuticals USA, Inc.3$151
Supernus Pharmaceuticals, Inc.1$125
Almatica Pharma LLC5$77
Alkermes, Inc.3$55
Neurocrine BioSciences, Inc.3$46

Products named: COBENFY, VRAYLAR, Auvelity, CAPLYTA, FANAPT, AUSTEDO XR, Qelbree, LOREEV XR.

Industry payments across NJ — which companies pay providers there.